For the diagnosis of anti-MAG polyneuropathy the commercial ELISA manufacturer currently recommends a cut-off of 1000 Bühlmann Titer Units (BTU). We analyzed sera from 80 anti-MAG neuropathy patients and 383 controls (with other neuropathies or healthy controls) to assess the ELISA sensitivity and specificity at different thresholds. A better combination of sensitivity/specificity was found at a threshold >1500 BTU than at >1000 BTU. The best value of specificity was obtained at threshold >7000 BTU. There was a diagnostic grey area between 1500 and 7000 BTU in which the clinical phenotypes as well as electrophysiological studies need to be carefully assessed particularly to differentiate CIDP and anti-MAG neuropathy.

Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy / Liberatore, G.; Giannotta, C.; Sajeev, B. P.; Morenghi, E.; Terenghi, F.; Gallia, F.; Doneddu, P. E.; Manganelli, F.; Cocito, D.; Filosto, M.; Antonini, G.; Cosentino, G.; Marfia, G. A.; Clerici, A. M.; Lauria, G.; Rosso, T.; Cavaletti, G.; Nobile-Orazio, E.. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 345:(2020). [10.1016/j.jneuroim.2020.577288]

Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy

Antonini G.;
2020

Abstract

For the diagnosis of anti-MAG polyneuropathy the commercial ELISA manufacturer currently recommends a cut-off of 1000 Bühlmann Titer Units (BTU). We analyzed sera from 80 anti-MAG neuropathy patients and 383 controls (with other neuropathies or healthy controls) to assess the ELISA sensitivity and specificity at different thresholds. A better combination of sensitivity/specificity was found at a threshold >1500 BTU than at >1000 BTU. The best value of specificity was obtained at threshold >7000 BTU. There was a diagnostic grey area between 1500 and 7000 BTU in which the clinical phenotypes as well as electrophysiological studies need to be carefully assessed particularly to differentiate CIDP and anti-MAG neuropathy.
2020
anti-MAG polyneuropathy; chronic inflammatory demyelinating polyradiculoneuropathy; ELISA; sensitivity; specificity; autoantibodies; case-control studies; enzyme-linked immunosorbent assay; humans; myelin-associated glycoprotein; polyneuropathies; retrospective studies
01 Pubblicazione su rivista::01a Articolo in rivista
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy / Liberatore, G.; Giannotta, C.; Sajeev, B. P.; Morenghi, E.; Terenghi, F.; Gallia, F.; Doneddu, P. E.; Manganelli, F.; Cocito, D.; Filosto, M.; Antonini, G.; Cosentino, G.; Marfia, G. A.; Clerici, A. M.; Lauria, G.; Rosso, T.; Cavaletti, G.; Nobile-Orazio, E.. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 345:(2020). [10.1016/j.jneuroim.2020.577288]
File allegati a questo prodotto
File Dimensione Formato  
Liberatore_Sensitivity_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 506.7 kB
Formato Adobe PDF
506.7 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1512252
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 26
social impact